Cosmo to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cosmo Pharmaceuticals (OTC:CMOPF) announced management will attend three investor conferences in March–May 2026 with scheduled one-on-one investor meetings.

Key dates: UBS European Healthcare Conference (London) on 4 March 2026; Jefferies Biotech Summit (Miami) on 11 March 2026; TP ICAP Healthcare Conference (Paris) on 7 May 2026. Investors may request meetings via investor.relations@cosmohc.com.

Dublin, Ireland--(Newsfile Corp. - February 18, 2026) - Cosmo Pharmaceuticals N.V. (“Cosmo”) is pleased to announce its participation in the following upcoming investor conferences:

UBS European Healthcare Conference 2026
London, United Kingdom
4 March 2026
Svetlana Sigalova, Chief Financial Officer, will participate in one-on-one meetings with investors.

Jefferies Biotech Summit 2026
Miami, United States
11 March 2026
Giovanni Di Napoli, Chief Executive Officer, will participate in one-on-one meetings with investors.

TP ICAP Healthcare Conference
Paris, France
7 May 2026
Members of the management team will participate in meetings with investors.

Investors attending any of the above conferences who would like to meet with Cosmo are welcome to contact the Company’s IR team to arrange an appointment via investor.relations@cosmohc.com.

About Cosmo
Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com.

For further information, please contact:
investor.relations@cosmohc.com

Attachments
PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284298

FAQ

When will Cosmo (CMOPF) present at the UBS European Healthcare Conference 2026 in London?

Cosmo will attend the UBS conference on 4 March 2026 with one-on-one investor meetings. According to Cosmo, CFO Svetlana Sigalova will hold one-on-one meetings with investors; interested parties should contact investor.relations@cosmohc.com to arrange appointments.

Who from Cosmo (CMOPF) will attend the Jefferies Biotech Summit 2026 in Miami and when?

Cosmo CEO Giovanni Di Napoli will attend the Jefferies Biotech Summit on 11 March 2026 for one-on-one meetings. According to Cosmo, investors can request meetings via investor.relations@cosmohc.com to schedule time with management.

Which Cosmo (CMOPF) executives will participate at the TP ICAP Healthcare Conference in Paris on 7 May 2026?

Members of Cosmo's management team will attend the TP ICAP conference on 7 May 2026 for investor meetings. According to Cosmo, multiple management representatives will meet with investors by appointment arranged through investor.relations@cosmohc.com.

How can investors schedule one-on-one meetings with Cosmo (CMOPF) at the March–May 2026 conferences?

Investors should contact Cosmo's IR team at investor.relations@cosmohc.com to arrange meetings. According to Cosmo, appointments for UBS (4 March), Jefferies (11 March) and TP ICAP (7 May) will be coordinated via the investor relations email.

Which investor events will Cosmo (CMOPF) attend in early 2026 and what is the geographic scope?

Cosmo will attend three investor conferences across Europe and the U.S. between March and May 2026. According to Cosmo, events include UBS in London (4 March), Jefferies in Miami (11 March) and TP ICAP in Paris (7 May).